Meet the Specialty Pharmacist Championing HIV Care
Cassandra Esperant, PharmD, AAHIVP, leverages her skills as a clinical pharmacist to champion the health of patients with HIV, both in her clinical practice and through education initiatives.
Keeping the Focus on Community Pharmacy Advocacy at the State Level
Drug Topics discussed independent pharmacy advocacy and PBM reform on the state level with Miguel Rodriguez, Executive Vice President and general counsel for American Pharmacies.
Navigating the Future: Key Technology Updates Every Community Pharmacist Should Know for 2024
Timothy Aungst, PharmD, Founder of The Digital Apothecary, discussed advancements in digital health and what to be aware of regarding the future of technology.
How Pharmacy Advocacy is Heating Up at the Federal Level
Drug Topics discussed independent pharmacy advocacy and PBM reform on the federal level with Miguel Rodriguez, Executive Vice President and general counsel for American Pharmacies.
Leveraging US Prescription Market Insights to Drive Pharmacy Innovation
Scott Biggs, Director of Supplier Services at IQVIA, discussed pharmacy trends within the industry and how pharmacists can stay ahead of them.
Guselkumab’s Promising Results as First Subcutaneous IL-23 Inhibitor to Treat Crohn’s
Johnson & Johnson announced results from its phase 3 GRAVITI trial exploring guselkumab’s results in subcutaneous (SC) induction and maintenance therapy for treating Crohn’s disease.
